Malaysia healthcare talent migration needs multi-agency effort
He said long-term solutions must involve collaboration across multiple agencies, as highlighted in an independent study by the Strategic Engagement Group (SEG) titled The Future of Health Workforce in Malaysia.
The study recommended the formation of an inter-ministerial Human Resource for Health (HRH) Governance Board to ensure sustainable workforce planning.
'This is not a challenge the MOH can resolve alone. We need the involvement of the Public Service Department, Ministry of Finance, Ministry of Higher Education, and the Ministry of Human Resources,' he said in a statement today.
Dr Dzulkefly stressed that the MOH is committed to strengthening the healthcare system through ongoing reforms in financing, and the adoption of digital tools, artificial intelligence, and other innovations to improve service delivery.
He also noted that as ASEAN Chair in 2025, Malaysia will prioritise healthcare workforce mobility and regional cooperation through deeper engagement with neighbouring countries.
His remarks followed recent claims that hospitals in Singapore are luring Malaysian public healthcare professionals, especially doctors, with attractive salaries.
Speaking earlier on the matter, he said the ministry is taking proactive steps to encourage healthcare workers to remain in the public sector, despite having no legal means to prevent overseas job offers.
Among the key initiatives are speeding up permanent appointments for contract doctors and enhancing workplace conditions to ensure a safer, more equitable, and supportive environment. - Bernama
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Straits Times
an hour ago
- New Straits Times
Hartamodal invests in Indian healthtech platform through RM70mil Dana Impian Fund
KUALA LUMPUR: Malaysian venture capital firm Hartamodal Sdn Bhd has made its first domestic investment through its RM70 million Dana Impian Fund, backing India-based healthtech platform Connect & Heal. It is a milestone for Hartamodal, the wholly-owned VC arm of Tradeview Capital Sdn Bhd, as it seeks to empower Malaysian entrepreneurs, both local and abroad, who demonstrate strong vision and execution capabilities. Hartamodal executive director Tan Cheng Wen said the investment represents its intention to support Malaysian founders with the ability to execute and help the country advance "We focus on backing founders with grit who can build and have the vision to tackle tough problems. "Dana Impian is all about giving opportunities to entrepreneurs and funding their dreams," he said in a statement today. Tan added that Connect & Heal's track record in India provided strong confidence in its potential for local replication. Dana Impian Fund, which targets earnings before interest, taxes, depreciation and amortisation-positive or cash flow-positive companies, invests between RM500,000 and RM10 million across sectors. This is particularly in healthcare technology, renewable energy, fintech, agritech, industrial manufacturing and consumer retail. Founded in 2017, Connect & Heal has grown into India's leading managed care platform, serving over six million lives across 450 cities and completing more than one million clinical transactions annually. The platform was co-founded by Galveen Kaur, Elwinder Singh and Salveen Kaur, alongside chief executive officer Sanjay Vinayak. The team chose to first build the business in India's challenging market, aiming to prove its scalability before expanding back into Malaysia. Its end-to-end care management services cater to multinational corporations and insurers, supporting over 600 organisations, including more than 30 Global Fortune 500 organisations.
Malay Mail
2 hours ago
- Malay Mail
Two-tier healthcare or public lifeline? Unpacking the debate over Rakan KKM
KUALA LUMPUR, July 15 — The Ministry of Health's (MOH) plan to launch its 'Rakan KKM' programme has ignited a fierce public debate. On one side, detractors warn it would create a two-tiered healthcare system that favours wealthier patients using public facilities. On the other, supporters argue the programme could help alleviate the financial strain on government hospitals and clinics while retaining specialist talent. What is Rakan KKM? The programme is a paid-for service envisioned by the MOH to offer 'premium economy' healthcare, encompassing elective procedures and personalised care. According to Health Minister Datuk Seri Dr Dzulkefly Ahmad, Rakan KKM will operate within the public healthcare ecosystem but provide services evocative of yet cheaper than commercial hospitals. The ministry aims to launch Rakan KKM by the third quarter of this year at four pilot locations: Hospital Cyberjaya, Hospital Putrajaya, Hospital Sultan Idris Shah Serdang, and the National Cancer Institute (IKN). Why the controversy? Criticism primarily centres on the argument that Rakan KKM amounts to a 'backdoor privatisation' of healthcare facilities and services funded by taxpayer money. Critics argue this will create a two-tiered system, allowing those with money to 'skip the line' for access to public healthcare services and bypass the long waiting lists that currently plague government hospitals under severe cost and manpower strains. They have also homed in on the salaries offered by Rakan KKM, with many top posts advertised with five-figure pay. Detractors have used this to question the MOH's stated inability to absorb thousands of contract health workers into permanent positions. Rakan KKM has so far received an allocation of RM25 million under Budget 2025, with a second phase of funding expected to come from government-linked investment companies (GLICs). The ministry's defence: Public interest, not profit Responding to the backlash, Dzulkefly has stressed that Rakan KKM's conception is underpinned by public interest. He rejected claims of privatisation by highlighting that Rakan KKM Sdn Bhd will remain fully owned by the Ministry of Finance Incorporated, which would keep the entity aligned with government objectives. 'When a GLIC investor comes in, the GLIC may take an equity stake in Rakan KKM Sdn Bhd. Ownership of Rakan KKM remains with the government, directly or through GLICs, throughout its operations,' the minister said on the social media platform X on Sunday. He then urged the public to look at the programme's key objectives, which he outlined as: Making healthcare more affordable than fully private options. Using any profits to cross-subsidise regular public healthcare services. Providing better income opportunities for specialists to retain them in the public service. Dzulkefly argues that these goals demonstrate that Rakan KKM is rooted in public service, not profit maximisation.
Barnama
3 hours ago
- Barnama
Malaysia To Host Medtec Sea 2025, ASEAN's Premier Medical Tech Conference
KUALA LUMPUR, July 14 (Bernama) -- Malaysia will host Medtec Southeast Asia 2025, the region's leading medical technology conference and exhibition, from July 16 to 18 at the Malaysia International Trade and Exhibition Centre (MITEC). The event, organised in conjunction with International Healthcare Week 2025 (IHW), is expected to bring together medical device regulators, manufacturers, innovators, and investors from across ASEAN to chart the region's future in the medical technology industry. Informa Markets regional portfolio director for Asean, Rungphech (Rose) Chitanuwat, who plays an influential role in shaping major trade exhibitions in Southeast Asia, said participants at IHW 2025 will have the unique advantage of exploring multiple healthcare sectors and attending 125 conference sessions tailored to diverse healthcare domains -- all under one roof. 'This integrated format eliminates the need to travel between separate events, allowing attendees to maximise their time and resources while gaining a comprehensive understanding of the latest market trends, innovative technologies and cutting-edge solutions,' she said in a statement to Bernama. Medtec Southeast Asia 2025 aims to position ASEAN as a major player in the global medical technology landscape by promoting cross-border collaboration, regulatory harmonisation and innovation. Meanwhile, MdDev Sdn Bhd, the conference partner, said this year's event is not just about networking but about advancing ASEAN's capabilities in medical technology to meet both regional and international healthcare demands. With the theme 'Driving Innovation & Manufacturing Excellence in the MedTech Ecosystem,' the event will focus on emerging areas such as medical device research and development, halal medical device certification, digital health solutions, and strategies for expanding market access across ASEAN and beyond. Participants will gain insights into transformative healthcare technologies, including artificial intelligence (AI) integration, augmented and virtual reality (AR/VR) applications in medical devices, and the Internet of Medical Things (IoMT). More than 40 sessions will be held over the three-day event, covering topics such as regulatory compliance, Industry 4.0 applications in medical device manufacturing, and strategies for market entry into ASEAN, the United States, Europe and other key regions.
